secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tectonic Therapeutic, Inc. (TECX)
CIK:        0001681087
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001140361-23-021828
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVROBIO CEO Geoff MacKay resigns; CFO Erik Ostrowski named interim CEO
----------------------------------------------------------------------

- CEO Geoff MacKay resigns effective May 1, 2023, to join an early-stage company; no disagreement with the company.
- CFO Erik Ostrowski appointed President and Interim CEO, effective May 1, 2023; will continue as CFO.
- Board of Directors begins search for a permanent CEO; Ostrowski has over 20 years of biotech finance experience.
- MacKay served as founding CEO for eight years; company transitioning to late-stage development for Gaucher and cystinosis programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681087/000114036123021828/0001140361-23-021828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681087/000114036123021828/ny20008949x1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-021828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer